|
|
||||||||
RESEARCH REPORT |
1 Department of Orthopaedic Surgery, University of California, San Francisco, CA 94110-1342, USA;
2 Department of Biomedical Engineering, Jonsson Engineering Center, Rensselaer Polytechnic Institute, Troy, NY 12180-3590, USA;
3 Faculty of Dentistry, Université de Montréal, Canada; and
4 Department of Plastic and Reconstructive Surgery, Stanford University, 257 Campus Drive, Room GK207, Stanford, CA 94305, USA
* corresponding author, brunsj{at}rpi.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: bone healing implants osteoblast
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS & METHODS |
|---|
|
|
|---|
Preparation of Empty Holes and Placement of Implants
All procedures followed protocols approved by the Institutional Committee on Animal Research. Adult wild-type mice (males, 3–5 mos old) were anesthetized. For empty holes, Ti alloy, and BioPin implants, a 0.8-mm hole was drilled in the anterio-proximal tibia and enlarged via a 1.0-mm drill to minimize bone damage, as previously described (Colnot et al., 2005). Implants were press-fitted into slightly undersized holes, and wounds were closed. For 303 SS implants, each pin was transfixed percutaneously in the proximal tibia, leaving only a small segment across the leg. Following surgery, mice received subcutaneous injections of buprenorphine for analgesia and were allowed to ambulate freely. Mice were killed at days 3, 5, 7, 10, 14, 21, and 28 post-surgery (n = 2 d3, 2 d7, and 3 d10 for 303 SS implants; n= 3 d3, 2 d5, 2 d7, 2 d10, 1 d14, 2 d21, and 2 d28 for Ti alloy implants; and n = 3 d3, 4 d5, 5 d7, 5 d10, 2 d14, 4 d21, and 3 d28 for BioPin implants).
Tissue Processing, Histology, and in situ Hybridization
Tibiae were dissected and processed as described (Colnot et al., 2003). Ti alloy and 303 SS implants were gently removed after decalcification and prior to dehydration, while BioPin implants dissolved during processing. Tissue sections were prepared for histology with Safranin-O Fast green (SO/FG) and Trichrome (TC), and for histochemistry with tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (AP). Adjacent sections were subjected to in situ hybridization analyses with collagen type I (Col1), collagen type (Col2)II, osteocalcin (Oc), osteopontin (Op), and runx2 (cbfa1) probes as previously described (Colnot et al., 2003).
Surface Characterization of Implants
Implant surface roughness was measured by optical interferometry (MicroXamTM; ADE Phase-Shift, Tucson, AZ, USA) at a resolution of 0.05 nm (vertical) and 0.3 µm (horizontal), with Sa = arithmetic average value of vertical departures of the profile or surface from the mean line throughout the sampling length or area; St = maximum peak-to-valley height of the entire measurement trace; and Sq = root mean square of values of all points of the profile. Implant surfaces were analyzed by ESCA (electron spectroscopy for chemical analysis) at NESAC/BIO (Univ. of Washington, Surface Science Instruments S-probe spectrometer), with x-ray spot size ~ 800 µm and sampling depth ~ 50 Å.
| RESULTS |
|---|
|
|
|---|
|
Histological analyses indicated that new bone formed in the empty implant site by d7. To pinpoint the actual onset of osteogenesis, rather than its histological manifestation, we conducted molecular analyses at earlier time-points. We examined expression of 3 genes: Collagen type I (Col I), Osteocalcin (Oc), and Osteopontin (Op). On d3, we identified cells in the injury site that expressed Col I (Fig. 2A
, arrow), suggesting initiation of an osteogenic program. The lack of Oc and Op expression in adjacent sections indicated that cells had not yet differentiated into osteoblasts (Figs. 2B, 2C
). The progressive increase in Col1, Oc, and Op expression from d5 to d7 indicated that cells initiated differentiation into osteoblasts during this window (Figs. 2D–2I
). These analyses provided a molecular map illustrating initiation of osteoblast differentiation and bone formation in an empty site.
|
|
Osteoblast Differentiation is Accelerated in the Presence of an Implant
Since new bone was detected earlier by histological analyses around implants vs. empty defects, we further analyzed early stages of healing. With implants present, Trichrome staining revealed a faint amount of Aniline-blue-positive matrix at d5 (Fig. 4A
, arrowhead). Alkaline phosphatase activity indicated the onset of mineralization (Fig. 4B
, arrows), and TRAP activity indicated matrix remodeling (Fig. 4C
). Thus, relative to an empty site, implant presence resulted in accelerated differentiation of peri-implant cells into osteoblasts, and acceleration in the remodeling of new bone matrix. We confirmed this using in situ hybridization, noting that cells around the implant up-regulated the osteoblast-related transcription factors Runx2 and Op at d3 (Figs. 4D, 4E
). Lack of Collagen type II (Col II) expression around the implant indicated that intra-membranous ossification was the mechanism of new bone formation at implant sites (Fig. 4F
).
|
| DISCUSSION |
|---|
|
|
|---|
Differences in Timing of Bone Formation around Implants and in Empty Holes
Analysis of our cellular and molecular data indicates that: (1) cells surrounding implants initiated differentiation into osteoblasts sooner than when no implant was at the site; and (2) the timing of osteoblast differentiation and new bone matrix deposition was equivalent among the three implant biomaterials. One explanation for this is that an implant provides a surface onto which osteoblasts can adhere and deposit a matrix that mineralizes, and that this surface was similar among our implants. The range of roughness values for our implants was narrow (Sa, 0.185–0.709 µm) and at the lower end of values for "smooth" (Sa, 0 to 0.4 µm) and "minimally rough" (Sa, 0.5 to 1.0 µm) implants (e.g., Sa ~ 0.46 for machined Brånemark implants). Also, our implants were not as rough as "moderately rough" (Sa, 0.5 to 1.0 µm) or "rough" (Sa, > 2.0 µm) implants, e.g., Sa ~ 0.91 µm for "OsseoSpeed" implants; and Sa ~ 1.6 µm for SLA implants (Albrektsson and Wennerberg, 2004; Ellingsen et al., 2004; Sul et al., 2005). While a recent review (Shalabi et al., 2006) reported "a positive effect on the bone response...from Ra/Sa of ~ 0.5 µm up to ~8.5 µm", our narrow Sa range was at the lower end of that range. Moreover, our ESCA data showed comparable values of carbon on surfaces of all implants. (Commercial Ti implants can also have high carbon levels on their surfaces; Wieland et al., 2000; Massaro et al., 2002.) Ultimately, quantitative analyses would complement our qualitative spatial and temporal gene expressions. For example, our in situ data from mice are consistent with Ogawa and Nishimuras (2006) RT-PCR data from tissues near Ti implants and at osteotomy sites in rat tibiae, which showed a 1.5- to two-fold up-regulation of collagen I, osteopontin, and osteocalcin expression (but not Runx2 and Bmp2) at 3 and 7 days after surgery.
Is Osseointegration Equivalent to Fracture Healing?
Concerning the oft-claimed analogy between fracture healing and interfacial healing (Brånemark et al., 1977; Brånemark, 1985; Pilliar and Simmons, 2002; Schatzker, 2002), both begin with a breach in an intact skeletal element, an immune response, neovascularization, and recruitment of skeletal progenitor cells. However, in a typical fracture, some skeletal progenitor cells differentiate into chondrocytes, while others differentiate into osteoblasts, followed by endochondral ossification. Around an implant, all skeletal progenitor cells differentiate directly into osteoblasts, followed by intramembranous ossification. Perhaps the key difference between fracture healing and interfacial healing is that the latter involves cellular and molecular responses that may be influenced by biomaterial surface texture, chemical composition, and implant biomechanics. In that context, advantages of the mouse model include its ability to allow for detailed molecular analyses, and the use of mouse mutants for the study of bone healing.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Received October 11, 2006; Last revision April 21, 2007; Accepted May 4, 2007
| REFERENCES |
|---|
|
|
|---|
Ask M, Lausmaa J, Kasemo B (1989). Preparation and surface spectroscopic characterization of oxide films on Ti 6Al 4V. Appl Surf Sci 35:283–301.
Berglundh T, Abrahamsson I, Lang NP, Lindhe J (2003). De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res 14:251–262.[ISI][Medline]
Brånemark PI (1985). Introduction to osseointegration. In: Tissue-integrated prostheses. Brånemark PI, Zarb G, Albrektsson T, editors. Chicago, IL: Quintessence, pp. 11–76.
Brånemark PI, Hansson BO, Adell R, Breine U, Lindström J, Hallen O, et al. (1977). Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl 16:1–132.[Medline]
Brunski JB (1999). In vivo bone response to biomechanical loading at the bone/dental-implant interface. Adv Dent Res 13:99–119.[Abstract]
Campbell TM, Wong WT, Mackie EJ (2003). Establishment of a model of cortical bone repair in mice. Calcif Tissue Int 73:49–55.[ISI][Medline]
Chiba S, Okada K, Lee K, Segre GV, Neer RM (2001). Molecular analysis of defect healing in rat diaphyseal bone. J Vet Med Sci 63:603–608.[ISI][Medline]
Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA (2003). Altered fracture repair in the absence of MMP9. Development 130:4123–4133.
Colnot C, Romero DM, Huang S, Helms JA (2005). Mechanisms of action of demineralized bone matrix in the repair of cortical bone defects. Clin Orthop Relat Res 435:69–78.[Medline]
Davies JE, Hosseini MM (2000). Histodynamics of endosseous wound healing. In: Bone engineering. Davies JE, editor. Toronto: Em Squared inc., pp. 1–14.
Ellingsen JE, Johansson CB, Wennerberg A, Holmen A (2004). Improved retention and bone-to-implant contact with fluoride-modified titanium implants. Int J Oral Maxillofac Implants 19:659–666.[ISI][Medline]
Esposito M, Thomsen P, Ericson LE, Sennerby L, Lekholm U (2000). Histopathologic observations on late oral implant failures. Clin Implant Dent Relat Res 2:18–32.[Medline]
Hoshaw SJ, Brunski JB, Cochran GV (1994). Mechanical loading of Brånemark implants affects interfacial bone modeling and remodeling. Int J Oral Maxillofac Implants 9:345–360.
Hoshaw SJ, Watson J, Schaffler M, Fyhrie D (1995). Microdamage at bone-implant interfaces affects bone remodeling activity. In: Transactions of the 41st Orthopaedic Research Society. Orlando, FL: Orthopaedic Research Society, p. 188.
Huja SS, Katona TR, Burr DB, Garetto LP, Roberts WE (1999). Microdamage adjacent to endosseous implants. Bone 25:217–222.[Medline]
Isidor F (1997). Histological evaluation of peri-implant bone at implants subjected to occlusal overload or plaque accumulation. Clin Oral Implants Res 8:1–9.[ISI][Medline]
Lazzara RJ, Testori T, Trisi P, Porter SS, Weinstein RL (1999). A human histologic analysis of osseotite and machined surfaces using implants with 2 opposing surfaces. Int J Periodont Rest Dent 19:117–129.
Massaro C, Rotolo P, De Riccardis F, Milella E, Napoli A, Wieland M, et al. (2002). Comparative investigation of the surface properties of commercial titanium dental implants. Part I: chemical composition. J Mater Sci Mater Med 13:535–548.[ISI][Medline]
Masuda T, Salvi GE, Offenbacher S, Felton DA, Cooper LF (1997). Cell and matrix reactions at titanium implants in surgically prepared rat tibiae. Int J Oral Maxillofac Implants 12:472–485.[ISI][Medline]
Monsees TK, Barth K, Tippelt S, Heidel K, Gorbunov A, Pompe W, et al. (2005). Effects of different titanium alloys and nanosize surface patterning on adhesion, differentiation, and orientation of osteoblast-like cells. Cells Tissues Organs 180:81–95.[ISI][Medline]
Nanci A, McCarthy GF, Zalzal S, Clokie CML, Warshawsky H, McKee MD (1994). Tissue response to titanium implants in the rat tibia: ultrastructural, immunocytochemical and lectin-cytochemical characterization of the bone-titanium interface. Cells Mater 4(1):1–30.
Ogawa T, Nishimura I (2006). Genes differentially expressed in titanium implant healing. J Dent Res 85:566–570.
Pilliar RM, Simmons CA (2002). Mechanical factors and osseointegration: influence of implant design. In: Aging, osteoporosis, and dental implants. Zarb G, Lekholm U, Albrektsson T, Tennenbaum H, editors. Chicago, IL: Quintessence, pp. 35–44.
Plenk HJ, Zitter H (1996). Material considerations. In: Endosseous implants: scientific and clinical aspects. Watzek G, editor. Chicago: Quintessence, pp. 63–99.
Pritchard JJ (1964). Histology of fracture repair. In: Modern trends in orthopedics. Clark JMP, editor. London: Butterworths, pp. 69–90.
Schatzker J (2002). Choosing a prosthesis for total hip replacement: biologic and biomechanical considerations. In: Aging, osteoporosis, and dental implants. Zarb G, Lekholm U, Albrektsson T, Tennenbaum H, editors. Chicago: Quintessence, pp. 45–52.
Schenk R, Hunziker EB (1994). Histological and ultrastructural features of fracture healing. In: Bone formation and repair. Brighton CT, Friedlaender GE, Lane JM, editors. Rosemont, IL: American Academy of Orthopaedic Surgeons, pp. 117–146.
Shalabi MM, Gortemaker A, Vant Hof MA, Jansen JA, Creugers NHJ (2006). Implant surface roughness and bone healing: a systematic review. J Dent Res 85:496–500.
Soballe K, Hansen ES, B-Rasmussen H, Jorgensen PH, Bunger C (1992). Tissue ingrowth into titanium and hydroxyapatite-coated implants during stable and unstable mechanical conditions. J Orthop Res 10:285–299.[ISI][Medline]
Sul YT, Johansson C, Wennerberg A, Cho LR, Chang BS, Albrektsson T (2005). Optimum surface properties of oxidized implants for reinforcement of osseointegration: surface chemistry, oxide thickness, porosity, roughness, and crystal structure. Int J Oral Maxillofac Implants 20:349–359.[ISI][Medline]
Sundgren JE, Bodo P, Lundstrom I, Berggren A, Hellem S (1985). Auger electron spectroscopic studies of stainless-steel implants. J Biomed Mater Res 19:663–671.[ISI][Medline]
Uusitalo H, Rantakokko J, Ahonen M, Jamsa T, Tuukkanen J, KaHari V, et al. (2001). A metaphyseal defect model of the femur for studies of murine bone healing. Bone 28:423–429.[Medline]
Wang ML, Sharkey PF, Tuan RS (2004). Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty 19:1028–1038.[ISI][Medline]
Watzak G, Zechner W, Ulm C, Tangl S, Tepper G, Watzek G (2005). Histologic and histomorphometric analysis of three types of dental implants following 18 months of occlusal loading: a preliminary study in baboons. Clin Oral Implants Res 16:408–416.[ISI][Medline]
Wieland M, Sittig C, Brunette DM, Textor M, Spencer ND (2000). Measurement and evaluation of the chemical composition and topography of titanium implant surfaces. In: Bone engineering. Davies JE, editor. Toronto: Em Squared, pp. 163–181.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |